Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flecainide CR in Paroxysmal Atrial Fibrillation
NCT00189319Phase 4Completed
- Sponsor
- Meda
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of flecainide in Atrial fibrillation (AFib), sponsored by Meda. Primary endpoint: Health-Related Quality of Life at 48 weeks. Started Sep 2003; status: completed.
02
Drugs
flecainide
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00189319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189319.